From the Company website -
ADAPT® Technology is the first and only next generation BioScaffold that completely re-engineers xenograft tissue into a pure collagen scaffold with optimized strength and pliability, superior biocompatibility and unparalleled durability.
Only ADAPT® Tissue Science has 10 years of clinical evidence demonstrating resistance to calcification.(1)
Only ADAPT® based 3D single piece Valve Design is anatomically correct to create less mechanical stress and optimal hemodynamics.(2)
ADAPT® is commercially available. Contact us for more information.
Can you post a link to those publications thanks.
Aortic Vale publications form Berlin and Munich Hospitals, page-2
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.71 |
Change
0.010(0.06%) |
Mkt cap ! $301.9M | |||
| Open | High | Low | Value | Volume |
| $16.00 | $16.01 | $15.49 | $3.254M | 230.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $15.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 700 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |